Down 75% in the Past Year, is Now a Good Time to Buy Shares of Gevo?

NASDAQ: GEVO | Gevo, Inc. News, Ratings, and Charts

GEVO – Clean energy company Gevo (GEVO) has made several positive developments. But is it wise to buy the stock now even though the company has not yet generated any revenue? Read on to learn our view.

Renewable fuels company Gevo, Inc. (GEVO) in Englewood, Colo., recently announced that it had begun bringing its wholly-owned dairy manure-based renewable natural gas project online and expects it to lead to annual distributions of $9 – $16 million. Also, in its December 2021 investor presentation, the company said that it has approximately $3 billion in financeable contracts in place and is negotiating an additional $30 billion in contracts with its “high-quality” customers.

However, its commercial supply arrangements will not begin until 2024. 

The stock has declined 49.4% in price over the past three months and 75% over the past year to close yesterday’s trading session at $3.61. In addition, it is currently trading 76.8% below its 52-week high of $15.57, which it hit on Feb.12, 2021, due to the Reddit-fueled short squeeze. Moreover, GEVO’s gross margin has been negative every year since 2012.

Here is what could influence GEVO’s performance in the upcoming months:

Poor Profitability

In terms of the trailing-12-month asset turnover ratio, GEVO is 99.3% lower than the 0.42% industry average. And the stock’s trailing-12-month ROCE, ROTC, and ROTA are negative compared to the 3.94%, 3.73%, and 1.26% respective industry averages.

Unfavorable Analyst Estimates

For the quarter ending March 31, 2022, analysts expect GEVO’s EPS to decrease 40% year-over-year. In addition, its EPS is expected to remain negative for the quarter ending March 31, 2022, and in its fiscal year 2022.

Stretched Valuation

In terms of forward P/S, GEVO’s 626.93x is significantly higher than the 1.58x industry average. And its 353.03x forward EV/S is considerably higher than the 2.54x industry average.

POWR Ratings Reflect Bleak Prospects

GEVO has an overall F rating, which equates to a Strong Sell in our POWR Ratings system. The POWR Ratings are calculated by considering 118 distinct factors, with each factor weighted to an optimal degree. 

Our proprietary rating system also evaluates each stock based on eight distinct categories. GEVO has an F grade for Quality, which is in sync with its lower-than-industry profitability ratios.

GEVO also has an F grade for Value, which is in sync with its higher-than-industry valuation ratios. In addition, the stock has an F grade for Stability, consistent with its 3.12 beta.

Furthermore, GEVO has a D grade for Sentiment. This is justified because analysts expect its EPS to decline in the near term.

GEVO is ranked #88 of 89 stocks in the Chemicals industry. Click here to access GEVO’s ratings for Growth and Momentum.

Bottom Line

GEVO is currently trading below its 50-day and 200-day moving averages of $4.26 and $6.06, respectively, indicating a downtrend. Because the stock looks overvalued at the current price level, we think it is best to avoid it now.

How Does Gevo (GEVO) Stack Up Against its Peers?

While GEVO has an overall POWR Rating of F, one might want to consider investing in the following Chemicals stocks with an A (Strong Buy) rating: Arkema S.A. (ARKAY), Covestro AG (COVTY), and Kronos Worldwide Inc (KRO).


GEVO shares were trading at $3.65 per share on Friday afternoon, up $0.04 (+1.11%). Year-to-date, GEVO has declined -14.72%, versus a -5.73% rise in the benchmark S&P 500 index during the same period.


About the Author: Nimesh Jaiswal


Nimesh Jaiswal's fervent interest in analyzing and interpreting financial data led him to a career as a financial analyst and journalist. The importance of financial statements in driving a stock’s price is the key approach that he follows while advising investors in his articles. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
GEVOGet RatingGet RatingGet Rating
ARKAYGet RatingGet RatingGet Rating
COVTYGet RatingGet RatingGet Rating
KROGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


Christmas in July for Stock Investors!

Yes, the S&P 500 (SPY) made new highs again on Tuesday. But really it is the 6X gain for the Russell 2000 small cap index Tuesday...and 12% gain this past week that is grabbing everyone’s attention. Let’s discuss why this is happening...if it will continue...and my 12 favorite stocks to rally in the weeks ahead. Read on for more...

3 Promising Tech Stocks Under $40 for Long-Term Investment

The increasing demand for technology services worldwide fuels the tech industry. Amid this backdrop, it could be wise to buy under $40 tech stocks, such as HP Inc. (HPQ), Box, Inc. (BOX), and Teradata Corp (TDC), for long-term investment. Continue reading…

3 MedTech Stocks to Add to Your Portfolio in July

The MedTech sector’s promising future is driven by technological advances, unceasing demand for medical treatments due to an aging population, and increasing global incidence of diseases. To that end, strong MedTech stocks such as Tactile Systems Technology (TCMD), Electromed (ELMD), and Embecta (EMBC) could be wise portfolio additions in July. Read more...

3 Bank Stocks Benefiting From High Interest Rates

Amid global economic uncertainties, major U.S. banks like JPMorgan (JPM), Wells Fargo & Company (WFC), and PNC Financial Services (PNC) have defied expectations with strong revenue and earnings reports for the second quarter. Considering their robust performance, investing in these stocks could offer stable returns to your portfolio. Read more…

Investor Alert: Load Up on Small Cap Stocks!

Large caps time in the sun is now over and thus no shock that the S&P 500 (SPY) pulled back from recent highs. It is time for small caps to shine which was clear in their nearly 4% gain Thursday even as the Magnificent 7 was bathed in red. Why is this happening? What comes next? And what are the best stocks to own now? The answers to all that and more are shared in the commentary below...

Read More Stories

More Gevo, Inc. (GEVO) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All GEVO News